NASDAQ - Moderna Inc / MODERNA - Trading Details

Product Description

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.


PARAMETERS Trading Specifications per Account Type
PREMIUM ZERO PRO
Spreads as low as 0.22 0.22 0.22
Size of 1 lot 100 shares 100 shares 100 shares
Minimum Contract size, lots 0.01 0.01 0.01
Maximum Contract size, lots 50 50 50
Tick value per 1 lot 1 USD 1 USD 1 USD
Volume limitation 50 lots per account 50 lots per account 50 lots per account
Margin requirement 4% 4% 4%
Minimum Price Increment 0.01 0.01 0.01
Limit and Stop Levels 15.0 15.0 15.0
Negative balance protection Yes Yes Yes
Swap free days allowance 0 0 0
chat icon